Ethypharm to borrow €285m for DB Ashbourne acquisition

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
LevFin
LevFin Leveraged Loans

Ethypharm to borrow €285m for DB Ashbourne acquisition

Max Bower
October 26, 2015 12:30 pm
cegedim12.jpg

Ethypharm, the French pharmaceutical company, is holding a bank meeting today (October 26) for €285.5m of new debt to finance the acquisition of DB Ashbourne, the UK branded drugs firm.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansNews contentLoans and High YieldLevFinLeveraged LoansLevFin Leveraged Loans
MB
Max Bower
Gift this article